glp 1 agonists adverse effects The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 Side Effect Profile of GLP-1
Description
Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same
Gastric inhibitory polypeptide (GIP) dosedependently stimulates glucagon secretion in healthy human subjects at euglycaemia

We dont know yet if it is better or worse, Jay says

[cited 2021 Feb 05]

"Most people don't fail GLP-1 medications because of the drug itself
